Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release

被引:149
作者
Ruan, Shaobo [1 ,2 ,3 ]
Zhou, Yang [1 ,2 ]
Jiang, Xinguo [4 ]
Gao, Huile [1 ,2 ]
机构
[1] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Educ Minist,Sichuan Engn Lab Plant Sourced Drug, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610041, Peoples R China
[3] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[4] Fudan Univ, Sch Pharm, Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
brain‐ targeting; drug delivery; dual‐ intracellular trafficking; stimulus‐ responsive; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; TUMOR MICROENVIRONMENT; ACETYLCHOLINE-RECEPTOR; ALZHEIMERS-DISEASE; MEDIATED TRANSPORT; PARKINSONS-DISEASE; GOLD NANOPARTICLES; ISCHEMIC-STROKE; SURFACE-DENSITY;
D O I
10.1002/advs.202004025
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The past decades have witnessed great progress in nanoparticle (NP)-based brain-targeting drug delivery systems, while their therapeutic potentials are yet to be fully exploited given that the majority of them are lost during the delivery process. Rational design of brain-targeting drug delivery systems requires a deep understanding of the entire delivery process along with the issues that they may encounter. Herein, this review first analyzes the typical delivery process of a systemically administrated NPs-based brain-targeting drug delivery system and proposes a six-step CRITID delivery cascade: circulation in systemic blood, recognizing receptor on blood-brain barrier (BBB), intracellular transport, diseased cell targeting after entering into parenchyma, internalization by diseased cells, and finally intracellular drug release. By dissecting the entire delivery process into six steps, this review seeks to provide a deep understanding of the issues that may restrict the delivery efficiency of brain-targeting drug delivery systems as well as the specific requirements that may guarantee minimal loss at each step. Currently developed strategies used for troubleshooting these issues are reviewed and some state-of-the-art design features meeting these requirements are highlighted. The CRITID delivery cascade can serve as a guideline for designing more efficient and specific brain-targeting drug delivery systems.
引用
收藏
页数:27
相关论文
共 206 条
[61]   Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer's disease [J].
Guo, Qian ;
Zheng, Xiaoyao ;
Yang, Peng ;
Pang, Xiaoying ;
Qian, Kang ;
Wang, Pengzhen ;
Xu, Shuting ;
Sheng, Dongyu ;
Wang, Liuchang ;
Cao, Jinxu ;
Lu, Wei ;
Zhang, Qizhi ;
Jiang, Xinguo .
ACTA PHARMACEUTICA SINICA B, 2019, 9 (03) :590-603
[62]   Trafficking and Proteolytic Processing of APP [J].
Haass, Christian ;
Kaether, Christoph ;
Thinakaran, Gopal ;
Sisodia, Sangram .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (05)
[63]   The Effect of Nanoparticle Polyethylene Glycol Surface Density on Ligand-Directed Tumor Targeting Studied in Vivo by Dual Modality Imaging [J].
Hak, Sjoerd ;
Helgesen, Emily ;
Hektoen, Helga H. ;
Huuse, Else Marie ;
Jarzyna, Peter A. ;
Mulder, Willem J. M. ;
Haraldseth, Olav ;
Davies, Catharina de Lange .
ACS NANO, 2012, 6 (06) :5648-5658
[64]   EORTC 10968:: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer [J].
Hamilton, A ;
Biganzoli, L ;
Coleman, R ;
Mauriac, L ;
Hennebert, P ;
Awada, A ;
Nooij, M ;
Beex, L ;
Piccart, M ;
Van Hoorebeeck, I ;
Bruning, P ;
de Valeriola, D .
ANNALS OF ONCOLOGY, 2002, 13 (06) :910-918
[65]   Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging [J].
Han, Liang ;
Kong, Derek K. ;
Zheng, Ming-qiang ;
Murikinati, Sasidhar ;
Ma, Chao ;
Yuan, Peng ;
Li, Liyuan ;
Tian, Daofeng ;
Cai, Qiang ;
Ye, Chunlin ;
Holden, Daniel ;
Park, June-Hee ;
Gao, Xiaobin ;
Thomas, Jean-Leon ;
Grutzendler, Jaime ;
Carson, Richard E. ;
Huang, Yiyun ;
Piepmeier, Joseph M. ;
Zhou, Jiangbing .
ACS NANO, 2016, 10 (04) :4209-4218
[66]   Properties of the glomerular barrier and mechanisms of proteinuria [J].
Haraldsson, Borje ;
Nystroem, Jenny ;
Deen, William M. .
PHYSIOLOGICAL REVIEWS, 2008, 88 (02) :451-487
[67]   Effect of pegylation on pharmaceuticals [J].
Harris, JM ;
Chess, RB .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) :214-221
[68]   Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis [J].
Henchcliffe, Claire ;
Beal, M. Flint .
NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (11) :600-609
[69]   Nanocarriers' entry into the cell: relevance to drug delivery [J].
Hillaireau, Herve ;
Couvreur, Patrick .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (17) :2873-2896
[70]   Detection of apoptosis in a rat model of focal cerebral ischemia using a homing peptide selected from in vivo phage display [J].
Hong, Hai-Yan ;
Choi, Jung Sook ;
Kim, Yoon Jung ;
Lee, Hwa Young ;
Kwak, Wonjung ;
Yoo, Jeongsoo ;
Lee, Jae-Tae ;
Kwon, Tae-Hwan ;
Kim, In-San ;
Han, Hyung-Soo ;
Lee, Byung-Heon .
JOURNAL OF CONTROLLED RELEASE, 2008, 131 (03) :167-172